The monoclonal antibodies in veterinary health market face growth opportunities due to rising animal chronic diseases and pet ...

Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of ...

Mindwalk identified TDP-43 antibodies that selectively target abnormal protein clumps linked to ALS and other diseases.

TOKYO -- The leader of Japanese opposition party Reiwa Shinsengumi, Taro Yamamoto, 51, announced on the party's YouTube ...

Multiple myeloma is the second most common blood cancer in the United States, and it is more common in men, with an estimated ...

Rising biotech investments and demand for therapeutic proteins are fueling rapid growth in protein expression systems, with mammalian cell platforms and essential reagents driving innovation. The ...

Kiniksa (KNSA) shifts from survival to growth as Arcalyst nears blockbuster sales and pipeline KPL-387 readouts loom—get the ...

Winter illnesses are slamming the U.S. A mutant influenza variant is sending scores of people to hospitals, 32 children have ...

GENE202 is a single dose gene therapy for patients with rare metabolic disease, methylmalonic acidaemia.

Shanghai Henlius Biotech, Inc. announced that it entered into an exclusive global license agreement with U-mab Biopharma ...